DONALD J. REYNOLDS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2017-04-26 Mr. Reynolds was appointed as a member of our Board of Directors on October 25, 2016. He serves on the Audit Committee, Compensation Committee, and Nominating and Governance Committee. Director compensation table shows $59,220 total compensation.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22